Lymph Node Ratio and Kras Mutation in R Colon Cancer
NCT04342676
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
433
Enrollment
OTHER
Sponsor class
Conditions
Colon Cancer Stage III
Interventions
DEVICE:
k ras
DRUG:
Panitumumab
Sponsor
Mansoura University